Danish biotech firm Zealand Pharma on Thursday said it will accelerate development and expand its research as it seeks to differentiate its experimental obesity drug candidates in an increasingly ...
Collaboration will combine Zealand Pharma's expertise in obesity and metabolic health with OTR Therapeutics' proprietary oral ...
Zealand Pharma A/S (Nasdaq: ZEAL) is a biotechnology company focused on advancing medicines for obesity and metabolic health. Combining more than 25 years of peptide R&D expertise with a proprietary ...
Jacksonville Journal-Courier on MSNOpinion
Commentary: America surrendering its biotech crown — Karen Kerrigan
Commentary: Health and Human Services justified its decision by citing public mistrust in vaccines based on mRNA technology, ...
The biotech sector has been a disaster for investors over the past five years going by a 14% decline compared to an 86% gain ...
Fermenta Biotech Limited (BSE: 506414) (Bloomberg: FERMENTA.IN) (Reuters: FERM.BO), India's leading manufacturer of ...
Study points to source of "very, very rare" cases of myocarditis and potential solutions. Myocarditis risk remains far higher ...
In the northwest corner of Sioux Falls, an 80-acre campus opened its first building this year dedicated entirely to expanding ...
Provisions on research security, grant policies, indirect cost rates, and more are packed into the latest version of the NDAA ...
In its latest Health Pulse report, Weber Shandwick surveyed synthetic audiences and pharma and biotech communications leaders ...
Rival European pharma giants Sanofi and GSK have both forged new partnerships to bolster their preclinical research. | Rival ...
EpilepsyGTx, a biotechnology company focused on research and development of cutting-edge gene therapies to treat refractory epilepsy, today announced it has raised $33 million in a Series A financing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback